MM&M spoke with Gazzaley about what's next for Akili, how he defines "digital medicine," and where the field is currently positioned on the hype cycle.
FDA Commissioner Dr. Scott Gottlieb has been saying all the right things regarding digital health.
Celgene reportedly in talks to buy Juno; Novartis' Kymriah receives fast-track reviews in U.S. and Europe; BI's Gilotrif gets expanded approval in lung cancer
New research calls into question the behavioral effects of some digital health tools.
Maker of Botox biosimilar Evolus files IPO; pharma execs expect major acquisitions in 2018; J&J and Bayer win Xarelto reversal verdict
Digital innovation in Japan, health-tech trends, and social media top the list.
Topping the list: The MM&M agency issue, the MM&M Awards winners and shortlist, and how a porn star is providing sex ed to seniors
The digital health startup was founded in 2015.
UnitedHealth Group to buy DaVita primary care unit for $4.9 billion; Roche drug combo doubles lung-cancer survival in trial; study: FDA programs expedite drug approval
Next year will be the start of the shift from marketing algorithms to AI, predicts Kantar Millward Brown.
Innovation-minded executives share their thoughts and predictions for the year ahead.
Botox-like wrinkle-reducer shows positive results in trials; investors double down on fertility; few websites transparent about pricing, study finds
CVS to buy Aetna for $69 billion; J&J buys commercial rights for biotech's experimental hypertension drug; Republicans repeal Obamacare's individual mandate
FDA approves first Apple Watch health accessory; medical charity shared data with pharma donors; FDA approves opioid-addiction treatment
How worried should the industry's other major players be?
The CEO's experience launching medical reference app Epocrates led him to found a social network for physicians.
Technology like this could expand further to form better collaborations between pharma, payers and organized providers.
FDA approves first digital pill; biotech companies race to develop cancer-fighting microbiome drugs; Loxo and Bayer reach $1.55 billion deal for rare cancer drugs
AI complements what we in pharma have always done best — respond to medical needs quickly and find solutions.
The CEO and founder of Antidote talks about what inspired him to start the company, which recently received funding from Merck.
The coming digital revolution will change a lot of things, but I guarantee this: It won't replace the importance of the patient-physician relationship.
Consumers younger than the age of 45 were most likely to use an app developed by their health plan.
FDA launches digital health pre-certification pilot; J&J's experimental RA drug raises safety concerns; AstraZeneca gets breakthrough status for Imfinzi
Amgen and Teva raise prices of leukemia drugs twice this year; Roche acquires diabetes app; docs use Snapchat to share patient scans
Lawmakers delay healthcare bill vote; Merck affected by cyberattack; more young people are having strokes
50% of consumers say they will share their health data with tech giants; pharma CEOs expect pricing proposal from Trump administration; FDA approves generic versions of Strattera
Siri and accessibility features take center stage in ads for Global Accessibility Awareness Day.
The artificial pancreas can provide value to the health system.
The FDA rejected an outcomes update to the Januvia label; digital-health funding dropped in Q1 of 2017; the FDA approves 23andMe's genetic test
Darine Ghanem is head of the scientific communications excellence group at Roche.